세계의 차세대 염기서열(NGS) 데이터 분석 시장 전망 : 시장 규모 분석(제품별, 워크플로우별, 모드별, 리드의 길이별, 최종 용도별, 지역별)과 예측(2022-2032년)

The global Next-generation Sequencing (NGS) Data Analysis Market was valued at approximately USD 811.86 million in 2023 and is projected to exhibit a robust compound annual growth rate (CAGR) of 23.10% during the forecast period from 2024 to 2032. NGS technology has revolutionized genomic research and diagnostics, offering unprecedented insights into complex biological phenomena. The decreasing cost of sequencing platforms, coupled with significant advancements in bioinformatics tools, has facilitated broader adoption in clinical and research settings.

The market is driven by the growing demand for efficient and scalable data analysis tools, particularly as NGS applications extend into oncology, rare disease diagnostics, and personalized medicine. Cloud-based bioinformatics platforms are gaining prominence for their ability to manage extensive genomic datasets with enhanced cost efficiency. Additionally, the advent of user-friendly software solutions, such as CLC Genomics Workbench and SevenBridges, has simplified complex genomic workflows, further boosting market penetration.

The market dynamics were notably influenced by the COVID-19 pandemic, as NGS technologies were pivotal in tracking viral mutations, developing diagnostics, and expediting vaccine research. These applications underscored the importance of robust sequencing data analysis tools, leading to increased investments from public and private sectors globally. Concurrently, advancements in tertiary data analysis have enabled deeper insights into genomic variation and functional genomics, facilitating novel therapeutic strategies.

While North America dominates the market owing to its advanced healthcare infrastructure and high R&D investments, Asia-Pacific is anticipated to experience the fastest growth due to rising adoption of precision medicine and increasing funding for genomic initiatives. In regions like China and India, government initiatives are actively promoting NGS adoption for tackling chronic diseases and enhancing healthcare delivery systems.

The market comprises leading players including Thermo Fisher Scientific, QIAGEN, Illumina, and Agilent Technologies, which continue to expand their portfolios with cutting-edge solutions tailored to diverse end-use applications.

Major market players included in this report are:

• 1. Thermo Fisher Scientific, Inc.
• 2. QIAGEN
• 3. Illumina, Inc.
• 4. Agilent Technologies Inc.
• 5. Pacific Biosciences of California, Inc.
• 6. Bio-Rad Laboratories, Inc.
• 7. F. Hoffmann-La Roche Ltd.
• 8. Eurofins Scientific
• 9. Partek Incorporated
• 10. DNASTAR, Inc.
• 11. SevenBridges Genomics
• 12. DNAnexus
• 13. Genedata AG
• 14. PerkinElmer Inc.
• 15. BaseSpace

The detailed segments and sub-segments of the market are explained below:

By Product:

• Services
• NGS Commercial Software
  • Platform OS/UI
  • Analytical Software
  • QC/Pre-processing Tools
  • Alignment Tools & Software
  • Others

By Workflow:

• Primary
• Secondary
  • Read Mapping
  • Variant Alignment & Variant Calling
• Tertiary
  • Variant Annotation
  • Application Specific

By Mode:

• In-house
• Outsourced

By Read Length:

• Short Read Sequencing
• Long Read Sequencing
• Very Long Read Sequencing

By End Use:

• Academic Research
• Clinical Research
• Hospitals & Clinics
• Pharma & Biotech Entities
• Other Users

By Region:

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approaches.
• Analysis of the competitive structure of the market.
• Demand-side and supply-side analysis of the market.

Table of Contents

Chapter 1. Global Next-generation Sequencing Data Analysis Market Executive Summary

• 1.1. Global Next-generation Sequencing Data Analysis Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Product
  • 1.3.2. By Workflow
  • 1.3.3. By Mode
  • 1.3.4. By Read Length
  • 1.3.5. By End Use
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Next-generation Sequencing Data Analysis Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory Frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Next-generation Sequencing Data Analysis Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Growing adoption in personalized medicine
  • 3.1.2. Rising demand for efficient data management systems
  • 3.1.3. Advances in cloud-based platforms
• 3.2. Market Challenges
  • 3.2.1. High costs of data analysis infrastructure
  • 3.2.2. Data management complexities
• 3.3. Market Opportunities
  • 3.3.1. Increasing use in oncology and rare disease research
  • 3.3.2. Technological innovations in tertiary analysis

Chapter 4. Global Next-generation Sequencing Data Analysis Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top Investment Opportunities
• 4.4. Top Winning Strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Next-generation Sequencing Data Analysis Market Size & Forecasts by Product (2022-2032)

• 5.1. Segment Dashboard
• 5.2. Global Next-generation Sequencing Data Analysis Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Million)
  • 5.2.1. Services
  • 5.2.2. NGS Commercial Software
    • 5.2.2.1. Platform OS/UI
    • 5.2.2.2. Analytical Software
    • 5.2.2.3. QC/Pre-processing Tools
    • 5.2.2.4. Alignment Tools & Software
      • 5.2.2.4.1. DNA Sequencing Alignment
      • 5.2.2.4.2. RNA Sequencing Alignment
      • 5.2.2.4.3. Protein Sequencing Alignment
    • 5.2.2.5. Others

Chapter 6. Global Next-generation Sequencing Data Analysis Market Size & Forecasts by Workflow (2022-2032)

• 6.1. Segment Dashboard
• 6.2. Global Next-generation Sequencing Data Analysis Market: Workflow Revenue Trend Analysis, 2022 & 2032 (USD Million)
  • 6.2.1. Primary Analysis
  • 6.2.2. Secondary Analysis
    • 6.2.2.1. Read Mapping
    • 6.2.2.2. Variant Alignment & Variant Calling
  • 6.2.3. Tertiary Analysis
    • 6.2.3.1. Variant Annotation
    • 6.2.3.2. Application-Specific Workflows
      • 6.2.3.2.1. Targeted Sequencing/Gene Panel
      • 6.2.3.2.2. Exome Sequencing
      • 6.2.3.2.3. RNA Sequencing
      • 6.2.3.2.4. Whole Genome Sequencing
      • 6.2.3.2.5. Chip Sequencing
      • 6.2.3.2.6. Others

Chapter 7. Global Next-generation Sequencing Data Analysis Market Size & Forecasts by Mode (2022-2032)

• 7.1. Segment Dashboard
• 7.2. Global Next-generation Sequencing Data Analysis Market: Mode Revenue Trend Analysis, 2022 & 2032 (USD Million)
  • 7.2.1. In-house
  • 7.2.2. Outsourced

Chapter 8. Global Next-generation Sequencing Data Analysis Market Size & Forecasts by Read Length (2022-2032)

• 8.1. Segment Dashboard
• 8.2. Global Next-generation Sequencing Data Analysis Market: Read Length Revenue Trend Analysis, 2022 & 2032 (USD Million)
  • 8.2.1. Short Read Sequencing
  • 8.2.2. Long Read Sequencing
  • 8.2.3. Very Long Read Sequencing

Chapter 9. Global Next-generation Sequencing Data Analysis Market Size & Forecasts by End Use (2022-2032)

• 9.1. Segment Dashboard
• 9.2. Global Next-generation Sequencing Data Analysis Market: End Use Revenue Trend Analysis, 2022 & 2032 (USD Million)
  • 9.2.1. Academic Research
  • 9.2.2. Clinical Research
  • 9.2.3. Hospitals & Clinics
  • 9.2.4. Pharma & Biotech Entities
  • 9.2.5. Other Users

Chapter 10. Global Next-generation Sequencing Data Analysis Market Size & Forecasts by Region (2022-2032)

• 10.1. North America Next-generation Sequencing Data Analysis Market
  • 10.1.1. U.S.
    • 10.1.1.1. Product breakdown size & forecasts, 2022-2032
    • 10.1.1.2. Workflow breakdown size & forecasts, 2022-2032
  • 10.1.2. Canada
  • 10.1.3. Mexico
• 10.2. Europe Next-generation Sequencing Data Analysis Market
  • 10.2.1. Germany
  • 10.2.2. UK
  • 10.2.3. France
  • 10.2.4. Italy
  • 10.2.5. Spain
  • 10.2.6. Rest of Europe
• 10.3. Asia Pacific Next-generation Sequencing Data Analysis Market
  • 10.3.1. China
  • 10.3.2. Japan
  • 10.3.3. India
  • 10.3.4. Australia
  • 10.3.5. South Korea
  • 10.3.6. Rest of Asia Pacific
• 10.4. Latin America Next-generation Sequencing Data Analysis Market
  • 10.4.1. Brazil
  • 10.4.2. Argentina
  • 10.4.3. Rest of Latin America
• 10.5. Middle East & Africa Next-generation Sequencing Data Analysis Market
  • 10.5.1. Saudi Arabia
  • 10.5.2. South Africa
  • 10.5.3. UAE
  • 10.5.4. Rest of Middle East & Africa

Chapter 11. Competitive Intelligence

• 11.1. Key Company SWOT Analysis
  • 11.1.1. Thermo Fisher Scientific
  • 11.1.2. Illumina, Inc.
  • 11.1.3. QIAGEN
• 11.2. Top Market Strategies
• 11.3. Company Profiles
  • 11.3.1. Thermo Fisher Scientific
  • 11.3.2. QIAGEN
  • 11.3.3. Agilent Technologies Inc.
  • 11.3.4. Bio-Rad Laboratories, Inc.
  • 11.3.5. Pacific Biosciences of California, Inc.
  • 11.3.6. Eurofins Scientific
  • 11.3.7. Partek Incorporated
  • 11.3.8. DNASTAR, Inc.
  • 11.3.9. SevenBridges Genomics
  • 11.3.10. DNAnexus
  • 11.3.11. Genedata AG
  • 11.3.12. PerkinElmer Inc.
  • 11.3.13. BaseSpace

Chapter 12. Research Process

• 12.1. Research Process
  • 12.1.1. Data Mining
  • 12.1.2. Analysis
  • 12.1.3. Market Estimation
  • 12.1.4. Validation
  • 12.1.5. Publishing
• 12.2. Research Attributes